Skip to main navigation Skip to search Skip to main content

Commercial Nanoparticles for Stem Cell Labeling and Tracking

  • Yaqi Wang*
  • , Chenjie Xu*
  • , Hooisweng Ow
  • *Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

52 Downloads (CityUHK Scholars)

Abstract

Stem cell therapy provides promising solutions for diseases and injuries that conventional medicines and therapies cannot effectively treat. To achieve its full therapeutic potentials, the homing process, survival, differentiation, and engraftment of stem cells post transplantation must be clearly understood. To address this need, non-invasive imaging technologies based on nanoparticles (NPs) have been developed to track transplanted stem cells. Here we summarize existing commercial NPs which can act as contrast agents of three commonly used imaging modalities, including fluorescence imaging, magnetic resonance imaging and photoacoustic imaging, for stem cell labeling and tracking. Specifically, we go through their technologies, industry distributors, applications and existing concerns in stem cell research. Finally, we provide an industry perspective on the potential challenges and future for the development of new NP products. © Ivyspring International Publisher.
Original languageEnglish
Pages (from-to)544-560
JournalTheranostics
Volume3
Issue number8
Online published20 Jul 2013
DOIs
Publication statusPublished - 2013
Externally publishedYes

Research Keywords

  • Cell therapy
  • Commercial nanoparticle
  • Imaging
  • Industry
  • Stem cell
  • Tracking

Publisher's Copyright Statement

  • This full text is made available under CC-BY-NC 4.0. https://creativecommons.org/licenses/by-nc/4.0/

Fingerprint

Dive into the research topics of 'Commercial Nanoparticles for Stem Cell Labeling and Tracking'. Together they form a unique fingerprint.

Cite this